(15331321), C. K. L., (15331324), A. R. A., (15331327), T. H., (15331330), J. Z., (15036467), D. K., (15331333), R. A. S., . . . (11678896), Y. W. (2025). Supplementary Figure S3 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis.
Trích dẫn kiểu Chicago (xuất bản lần thứ 7)(15331321), Chong Kin Liam, et al. Supplementary Figure S3 from Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis. 2025.
Trích dẫn kiểu MLA (xuất bản lần thứ 9)(15331321), Chong Kin Liam, et al. Supplementary Figure S3 from Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis. 2025.